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University of Edinburgh, UK
Summary. This paper argues for the inclusion of ethnography as a research
methodology for understanding the eﬀects of public health policy. To do this,
the implementation of DOTS (Directly Observed Therapy, Short-course) –
the World Health Organization (WHO) prescribed policy for the control
of the infectious disease tuberculosis – is explored in the context of Nepal. A
brief history of DOTS and its implementation in Nepal is outlined, and the
way it has been represented by those within the Nepal Tuberculosis
Programme (NTP) is described. This is followed by an outline of the research
done in relation to this, and the ethnographic methods used. These
ethnographic data are then interpreted and analysed in relation to two
specific areas of concern. Firstly, the eﬀects around the epidemiological uses
of ‘cases’ is explored; it is argued that a tightening of the definitional
categories so necessary for the programme to be stabilized for comparative
purposes has profound material eﬀects in marginalizing some from treatment.
Secondly, the paper examines some of the implications and eﬀects relating to
the way that the ‘directly observed’ component was implemented. The
discussion explores how current debate on DOTS has been played out in
some medical journals. It argues for the importance of ethnography as a
method for understanding certain questions that cannot be answered by
particular, and increasingly dominant, research ideologies informed by
randomized controlled trials. This raises important issues about the nature of
‘evidence’ in debates on the relationship of research to policy.
DOTS in Nepal
Directly Observed Therapy, Short-course (DOTS) policy includes five essential
elements, namely: political commitment to increasing resources and including
tuberculosis (TB) control as an activity integral to national health systems; good,
widely available sputum microscopy services so that the disease can be correctly
identified; standardized short-course chemotherapy, including the direct observation
of treatment; uninterrupted supply of drugs; and, finally, recording and reporting
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systems (WHO, 2002). In Nepal, following a joint HMG/WHO review of the Nepal
National Tuberculosis Programme (NTP) in 1994, DOTS was adopted as national
policy in 1995, with implementation starting in early 1996. Positive results in four
districts led to expansion covering about 20% of the population by mid-1998. The
whole programme remains oriented towards the ‘internationally’ (that is WHO)
defined targets of finding 70%, and curing 85%, of patients with infective tuberculosis.
Simultaneously, in 1993 the Tuberculosis Control Network was started, in which a
number of NGOs working in the realm of TB control linked up with the NTP to
address issues of common concern. These included standardizing treatment protocols,
manuals and the organizational recording and reporting formats so that program-
matic comparisons and the training of staﬀ would be consistent and easier. By 1999,
when the fieldwork upon which this paper is based was ongoing, the programme had
been expanded to cover over 50% of the country. By 2001 the head of the National
programme was able to represent the programme in the following way on a website
set up to deal with global tuberculosis issues, to showcase Nepal as an exemplar of
what is possible to achieve with DOTS:
DOTS was introduced in 1996 after a joint His Majesty’s Government of Nepal (HMG/N)/WHO
review of the National Tuberculosis Programme (NTP) revealed that only 30% of TB cases were
registered under the NTP and of these, only 40% were treatment successes. The cure rate in the
first cohort of DOTS patients was above 89%. By July 2000, the programme had been expanded
to 183 treatment centres in 69 districts and covers 78% of population. The treatment success rate
in the DOTS centres remains at approximately 89%, with the national treatment success rate now
reaching almost 85%. Nationally, this year over 28,000 TB patients have been registered and are
being treated under the NTP. Out of these, over 75% are being treated under DOTS. (Bam, 2001)
This needs to be placed within the context of the overall delivery of primary health
care services. Economically, by the year 1999 total spending on health care in Nepal’s
public sector remained grossly under-funded at US$1·8 per capita per year, rising to
US$3·1 when donor funding was taken into account. It remained at about
one-quarter of the level needed to provide even a basic essential package of health
services in a developing country, as suggested by the World Bank (World Bank,
1999). Within this, the annual funding for the National Tuberculosis Programme from
the government rose from 25 million rupees (1 US$x69 NPR) in 1995/96 to 63·5
million rupees in 1998/99 (NTP & HMG/N, 1999). Assistance from a number of other
sources added another US$2·5 million. The Department for International Develop-
ment (DfID-UK), the International Union Against Tuberculosis and Lung Disease
(IUATLD), the Japanese International Co-operation Agency (JICA), the Japanese
Government, the Norwegian Lung and Heart Foundation, NORAD, the Nuﬃeld
Institute for Health, the Research Institute of Tuberculosis, Japan, and the WHO
assisted at the national level financially, technically and with research. Programme
implementation was assisted at a regional and district level by a number of
international and national non-governmental organizations (INGOs and NGOs).
Structurally, the National Tuberculosis Centre, the building, lies some distance from
the Department of Health Services. Although the National Tuberculosis Programme
is said to be ‘integrated’ into the national health system, the Director of the National
Tuberculosis Centre (NTC) also manages the NTP, and the agenda remained very
much a vertical disease programme. The NTC, and their staﬀ, provided the technical
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support (planning, monitoring, training, supervision, logistics, laboratory services,
health information education and research) to the TB control activities, at national,
regional and district levels (NTP & HMG/N, 1999).
The expansion of the programme started in the districts that had been able to
adhere to the strict protocols for the introduction of short-course chemotherapy
(SCC). Short-course chemotherapy is called ‘short-course’ as it replaced the standard
drug regimes of the past with an entirely oral one that substituted the injectable
streptomycin with the drug rifampicin, and the regime needed only be given for six
to eight months rather than a year. In Nepal, DOTS was adopted as national policy
following the gift of free rifampicin from the Japanese Government, as part of their
aid package, to the National Tuberculosis Programme and amid fears that this would
produce an epidemic of multi-drug resistant TB (MDR-TB) once the markets were
flooded with this drug (Fryatt, 1995). National DOTS policy rapidly expanded to
include most districts of Nepal. As a part of the above collaborative research eﬀorts
in Palpa District – one of the 75 administrative districts into which Nepal is divided,
and where I did most of my fieldwork – had been randomized as a part of a trial
comparing the use of female community health volunteers (FCHVs) with family
DOTS. This was one of the areas that the NTP, heavily influenced by the WHO, had
identified as important to research: namely ways to implement the DOT component
of the DOTS programme. Diﬀering treatments in Palpa up to this time were available
from a range of private doctors and pharmacies, including a mission hospital. The
DOTS clinic was set up in the public hospital and the free treatment through
the revitalized National Tuberculosis Programme was being made available from the
state-run primary health centres and health posts. Prior to its introduction, a whole
series of training sessions were conducted at the district centre, and from health posts,
to raise awareness of the programme. These were facilitated by staﬀ from the NTP.
All health workers were targeted, as well as the FCHVs. Simultaneously, new
recording and reporting strictures were introduced, along with new protocols for the
treatment of patients. Regular meetings were instituted and held at health posts and
in the district centres every four months to facilitate the reporting of outcomes to the
centre, and the reordering of drugs based on consumption patterns.
Methods
My research in anthropology sought to understand how a number of public health
programmes, of which DOTS was one, were taken up and translated in practice
within the health services in Nepal. In order to do this research I did fieldwork in the
form of participant observation from September 1998 to March 2000. This, the
process of doing ethnography, is simply based on the premise that one of the best
ways to understand a situation is to spend extended periods of time interacting with
those involved in that situation (Monaghan & Just, 2000). This research involved
spending long periods of time with staﬀ in hospitals, health posts and TB clinics
and working with the TB programme supervisors as they implemented the new policy
and protocols; following up in the long term those diagnosed with the disease and
attempting to understand the meaning they attributed to it within the contexts of their
lives; understanding how both the ill, and those delivering biomedical services,
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negotiated the diagnostic possibilities in an area where being ill can be dealt with by
a richly diverse range of healers; and trying to understand how the rapidly increasing
private pharmacies and national bureaucratic health services were integrated into this
mosaic locally.
I started with a series of broadly stated and open-ended questions related to the
above. Over time and during the process of observing, participating in, and
questioning around what was happening I was able to acquire an understanding of
these activities relating to health. As trust developed between myself and my subjects
of research, and by allowing conversations to wander to the interests of the staﬀ and
patients, I was granted access into areas of their work and lives that no amount of
questionnaires could generate. I have also been trained as a medical doctor and had
worked in TB clinics so I was able to discuss the concerns of the staﬀ in relation to
the work. Much of the data, then, were dependent upon my own subject position: that
is how I was perceived by those I was researching with and the influence this had on
how they interacted with me.
Descriptive ethnography and interpretation
Case deﬁnitions and programmatic representation
The findings were multifaceted generating both support for the current policy and
significant challenges to aspects of it. At a national level and translated down to the
district, the raised awareness and political will to deal with TB were increased
substantially, and this heightened public awareness of tuberculosis as a health
problem. Health staﬀ became both more aware of tuberculosis as a disease and of the
need to treat it for sustained periods and the dangers of interrupted treatment. By
standardizing recording and reporting formats, it became possible to follow up and
report on outcomes, something that was limited prior to the start of the DOTS
programme itself. Short-course chemotherapy was introduced and drug supplies
improved. The standardizing of treatment protocols and the diagnostic categories (i.e.
what makes a ‘new smear positive case’ etc.) and the training involved for staﬀ
disseminating this, resulted in increased collaboration between some institutions.
Cross-referrals between hospitals and clinics became possible, without the complex
task of having to change drug regimes. From this broad perspective, then, as with
those who suggest that we should limit our criticisms of DOTS to the pre-DOTS
‘chaos’ that I discuss later, there were significant, and from the perspective of the
control of tuberculosis, positive changes.
However, such a picture would be misleading if other issues were not also touched
upon. The standardizing of the definition of categories of patients, so necessary for
programmatic comparative purposes, resulted in the emergence of a whole new set of
diﬃculties. A ‘new’ smear positive patient, here as everywhere, was redefined as
anyone presenting to the health centre for the first time, and having received less than
one month’s treatment from elsewhere. Within epidemiology, it is inevitably the case
that if one is to compare programmatic performance and output, a tight definition of
a ‘case’ of tuberculosis is necessary. But one of the unintended consequences of this
drive to compare, at least in the district of Palpa, was that about 20% (as the staﬀ
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and I calculated in the DOTS clinic) of patients presenting to the clinic who had
received more than a month’s treatment from the private sector were not being
allowed into the National Tuberculosis Programme. As more than 200 were registered
into the programme this is a significant number. Paramedical staﬀ had been trained
to implement the new protocols, but they had not been taught (the admittedly
complex) task of deciding what to do for these pharmaceutically complicated patients.
During discussions with staﬀ about the diﬃculties they faced in their work, they
frequently referred to the training and seminars that they had been sent to, organized
by the NTC in Kathmandu. Some of the explanations and diﬃculties encountered in
categorizing patients along the new NTP guidelines were as follows. How was it
possible to know that these patients presenting to the NTP had tuberculosis in the
first place – they may not have had tuberculosis at all and been placed inappropriately
on treatment? Even if they had, they may or may not have been ‘smear positive’ (the
diagnosis protocol states that this is dependent upon visualizing the causative
organism in the sputum under a microscope). If they were ‘smear positive’, and they
had taken their drugs intermittently, then they could already be ‘resistant’ to first-line
treatment, the drugs recommended for those in this category. However, they were not
strictly ‘re-treatment’ cases either – another centrally defined category. For this there
needed to be proven defaulting from treatment, or it was necessary to know that they
had completed treatment and were labelled as ‘relapsed’. In discussion with the clinic
staﬀ, given that their autonomy to make individual decisions had been restricted and
curtailed by the research and diagnostic protocols, they struggled continually to place
patients into these categories.
Now policy allowed that the qualified doctor in the public hospitals made
decisions around these pharmacologically complex, and potentially drug-resistant
patients. In this district (and indeed in many others, particularly the remoter ones),
however, these doctors were frequently absent, often for months at a time, and were
not replaced. It was ironic in the extreme, that for a period of three months during
my research one such doctor in Palpa was at a training course in Thailand on
understanding infectious disease surveillance! But the consequence was that unsup-
ported, all the junior staﬀ could do was to deny these medically complex patients
further management within the system, and they were referred back to the hugely
expanding private sector to further receive their potentially erratic treatment.
This ethnographic information, gathered after a long period with staﬀ in the
district, raises many important questions overlooked by public health specialists and
researchers in Nepal. Firstly, is it possible that the very programme designed to
prevent the rise of MDR-TB is unwittingly complicit in its generation and spread?
While individual compliance is continuously reiterated as the major cause of this –
and the justification for DOT – ethnographic data suggest that other factors may be
as big a problem. Secondly, as pharmacologically complex patients are not even
allowed entry into the NTP figures, it is likely that at the very least the oﬃcial figures
significantly overestimate the success of the programme. Those most likely to be cured
are the ones entered into the NTP, while those least likely to be cured – those whose
treatment has been interrupted – are denied access. Not included in current figures are
these cohorts who do not get in. It is probable, therefore, that the most likely to
develop MDR-TB are not even a part of the figures. This becomes a vitally important
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question of interpretive framing, and how national data are presented, as much as
about the ‘facts’ themselves. It is also clear that the desire for accurate cohort
information and the tightening of definitional and diagnostic categories may also be
a part of the problem itself as the social processes that generate the facts, through
processes of exclusion, simultaneously distort the nature of the reality it seeks to
represent.
The problems with Direct Observation of Therapy
Palpa District, as a part of the trial comparing direct observation possibilities, had
been randomized so that local female community health volunteers (FCHVs) were
used for this purpose. For many of the ill, those fortunate enough to live close to
health centres and these volunteer staﬀ, this was frequently helpful. Mobilizing these
workers and training them helped raise awareness of tuberculosis and that it was a
treatable, infectious disease. Quite quickly, however, it became possible to recognize
that this form of support was not always in the patients’ best interest. Patients were
informed upon being registered into the programme that they had to return to the
clinic with the volunteer to receive treatment and instructions. These volunteers,
rather than the patients themselves, were then entrusted with dispensing the
medicines, and directly observing that they were swallowed. One man I followed up
who had not returned to a health post with the FCHV as instructed had been too
busy with the rice harvest. He had died without even receiving treatment. Another
man I interviewed who had been severely debilitated as a consequence of his disease
pointed out how diﬃcult it was to walk anywhere in these steep mountainous regions
if you had tuberculosis. Several of the FCHVs I visited on one trip, themselves
local women and equally busy, were just giving the drugs to patients often for a
month at a time. Moreover, at one training session I attended, they complained that
they were expected to do more and more work (pulse polio, Vitamin A distribution,
and other health monitoring activities for example) as they had become the focus of
considerable eﬀorts to improve health service provision.
But there were a number of other reasons why the direct observation of the
treatment was frequently diﬃcult. Many with the disease, particularly younger
women, wished to avoid the stigma associated with it. For many this was a disease
linked to notions of impurity, and locally widely associated with dirt and poor habits
like drinking and smoking. The shame associated with having the disease, and the
understandable desire to remain anonymous while receiving treatment, became harder
with this system. The increased surveillance made issues of patient confidentiality all
but impossible. The disease and ideas around its causes were also frequently
interpreted into the dominant caste ideology in the area. One consequence was a
general reluctance for many of the higher caste supervisors – and nearly all the
supervisors were higher caste – to oﬀer water to lower caste patients with the disease,
to help in swallowing their tablets. This relates to religiously sanctioned notions of
purity and impurity, defined by the dominant and mainly Hindu religious ideology in
the area. A consequence, as was pointed out by several health workers I had
conversations with, was that this support added to the reasons for default for some
lower caste patients.
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Also in a health structure that reflects some of the broader social hierarchies (cf.
Nichter & Nichter, 1996, for an Indian comparison) more senior members of the NTP
and supervisors frequently did not listen to the valid suggestions of the staﬀ, such as
being more flexible with direct observation. Supervisors just demanded – frequently in
long monologic speeches to the staﬀ – that this district policy be continued. When the
staﬀ at one district level meeting suggested that just using FCHVs was not practical,
the response from one regional supervisor was that they just had to carry on. Using
FCHVs was national policy the group was informed. There was a tendency, also, for
senior staﬀ to suggest that those below them in the hierarchy ‘did not understand’ the
necessity for daily observation and so required further training and further technical
instruction into its necessity. As a consequence of this, as I was told by one health
worker, what they needed to do to keep their jobs and not be transferred was to tell
their bosses what it was that they wanted to hear. A number of staﬀ understood that
DOT was not in the interests of the patients and ignored it, and attempted innovative
ways of adapting their procedures, giving weekly drugs or more to the patients as they
arrived, for example. But other health workers hid behind the DOTS ‘rules’ inflexibly.
One DOTS worker I sat with would not give a week’s worth of drugs for patients to
travel to his relative’s home at an important festival time. It was for reasons like this
that another health worker dubbed the DOTS programme the ‘defaulter creation
system’.
There are, then, a variety of social relations, some broadly speaking cultural and
others linked to hierarchy in the health system, into which the DOTS programme
falls. Both health workers’ and patients’ reactions to the implementation of this
programme were varied. But my own research experience suggests that given the right
conditions and supervisory support, most of the staﬀ would work out appropriate
strategies for dealing with the vexed question of adherence to treatment. This requires
a diﬀerent relationship, however, with the staﬀ, and an understanding of how the
rigid requirements of a research agenda linked to the health service can feed
counterproductively (from the perspective of patient support) into already existing
social hierarchies.
Discussion
In 2004, the WHO published its 8th annual report on global tuberculosis control
(WHO, 2004). Two hundred and one countries – including Nepal – reported on their
strategies for TB control, as well as on their TB case notification and treatment
outcomes. This in itself is a remarkable achievement, as in 1990 assessment in most
developing countries was virtually non-existent, because of the poor development of
information systems, both at country and global levels (Raviglione, 2003). This shift
was facilitated by the development of the DOTS strategy, spearheaded by the WHO,
and which has been aggressively promoted via strategies that marketed the approach
to policy-makers and programme implementers. As the 2004 global report introduces
it, DOTS is ‘a management strategy for public health systems’, not guidelines for
individual clinicians (WHO, 2004, p. 11). One consequence of its simplification and
marketing has been a rift and considerable disagreement between those who advocate
it, and a number of researchers and academics who felt that it was too simplistic
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(Ogden et al., 2003). Within this, and in the published literature, most of the criticisms
of the DOTS strategy have fallen onto the ‘direct observation’ component. The
uncritical insistence that DOT is a mandatory component of this strategy has led
some commentators to suggest this places a primacy in ‘faith’ over that of ‘science’
(Garner & Volmink, 2003), and that the structure and functioning of DOTS
programmes have not been substantiated in rigorous, empirically based trials (Mudur,
2004). The defence of the DOTS strategy by those who advocate it, has been to
underplay the DOT component of it and highlight how it acts to mobilize resources,
secure regular supplies of drugs, increase political commitment and improve moni-
toring of outcomes (see, for example, Gunneberg, 2004) – or that what is important
to consider is the comparison of ‘the ramshackle chaos of a pre-DOT programme
with a new DOT programme in the same setting’ (Davies, 2003).
Most of the arguments for and against DOT have been developed from evidence
of a few key trials that have compared direct observation of treatment with that of
self-treatment (Zwarenstein et al., 1998, 2000; Kamolratanakul et al., 1999; Walley
et al., 2001). It is on the basis of the evidence in these internationally published
papers – based on research in South Africa, Pakistan and Thailand – that Garner and
Volmink set up their 2003 editorial questioning DOT in the British Medical Journal
(Garner & Volmink, 2003). This highlights an important aspect of the debate as
played out in medical journals: that what is most frequently valorized is a particular
logic of scientific enquiry – the randomized controlled trial – as the authority and
grounds for comment. This is despite an increase in the number of calls for
cross-disciplinary research and good examples of this (see, for example, the
contributions to Porter & Grange, 1999), and that there is already much research
focusing on socio-cultural and political–economic issues in social science and
anthropology journals that have focused on tuberculosis (Ho, 2004).
While the WHO have recently acknowledged that randomized controlled trials are
limited in their use for evaluating DOTS (something they argue strategically and most
strongly when these trials question the value of DOT), they still warn that it is
essential that ethical consideration needs ‘to be given to any study design that diﬀers
from globally recommended policy, and in most countries, national policy as well’
(Maher et al., 2003). While I think that it is disingenuous to defer to the higher
authority of an undefined ‘ethics’ in defence of DOT, it is to be commended that the
WHO recognize the need for a greater methodological diversity in understanding the
impact and eﬀects of the DOTS programme in a variety of settings (Ibid.). More
concretely, also in response to this editorial, Macq suggests that it is important to
develop methodologies that move away from statistical and ‘inference-based’ reflec-
tion, to ones that promote context-sensitive and qualitative knowledge generation
(Macq, 2004).
Here questions surface around the complex relationship between more positivist
scientific disciplines and those that are reflexively more interpretive. The relevance of
local, nuanced data that are generated through a research method that is ‘inter-
subjective’ rather than claiming to be objective is at stake here. This raises questions,
too, around the generalizability of what can be inferred from such research data. How
do we anthropologists defend, then, what we deem our disciplinary strength:
understanding the local, the particular and all the nuance of human interaction within
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broad historical, social and political fields? What is the relevance to medical and
public health discourse, whose frames for veriﬁability and generalizability, are still
largely unchallengable? The diﬃculties of engaging work that is inter-subjective,
frequently literary in writing style and very local with work that is positivistic, based
in ‘enlightenment’ principles and for broad population-based policy agendas should
not be underestimated (Kleinman, 1995). I have presented aspects of my work to
those involved in the programme in Nepal – from the WHO advisor to others – but
the response was a form of silencing, by asking in what sense my findings in Nepal
were generalizable to the rest of Nepal. It was pointed out that policy could not be
dependent on data – deemed anyway to be in the main little more than my own
opinion (i.e. too subjective and interpretive) – from just one small area. Given that
the policy itself was also not based on much evidence this argument seems
disingenuous, but more importantly it raises issues on the relations of policy with
research, and of the relationship between value and science. Once a particular policy
gains momentum, political expediency becomes the primary driving force, and in its
wake the burden of proof required to challenge predefined policy rises.
For audiences informed by this scientific ideology, how might we clear the space
for a more anthropological agenda? This must be more than adding a few methods
to do ‘the cultural piece’ (Farmer, 1999); that is, the type of research that seeks to
understand cultural practices and beliefs that act as ‘barriers’ to control or as reasons
for default from treatment, for example. While there may be a place for this type of
research, this is just one strain of medical anthropology, called by Byron Good ‘the
persistence of the empiricist tradition’ (Good, 1994). Anthropology has much more
than this to oﬀer. At its best anthropology is able to ‘reconfigure the boundaries of
the problem’, oﬀering (new) conceptual frameworks, substantive knowledge and
methodological insights (Lambert & McKevitt, 2002). The work of Paul Farmer is
but one example, as he brings in a broader political and economic frame, issues of
‘structural violence’ and how this impinges on the more vulnerable and marginalized
in both developing tuberculosis, and how their lack of agency limits their consequent
access to treatment (see, for example, Farmer, 1999). The findings presented in this
paper highlight the mistaken assumptions embedded in public policy: that research
clearly needs to include within its frame an exploration of the unintended eﬀects of
policy and research itself; the need for greater critical awareness of the conceptual
framing devices, and the biases of programmatic representations. In the light of this
work I would call for much greater flexibility in implementation strategies of TB
control.
While there is a range of important research currently being conducted under the
auspices of, and in partnership with, the NTP in Nepal, this could be considerably
strengthened by considering the value of, and need for, more qualitative research.
None of it focuses on the more historical, political and economic issues. Conceptually,
the narrowing of fields of vision of current research from the NTP, so obviously
defined by a dominant medical ideology, is unlikely to pose these more diﬃcult
questions; this at present comes from the perspective of the stabilization of the system
(see I. Harper, in press) rather than the perspectives of the patients. To understand
why default occurs, as one example, requires this broader conceptualization and
cannot be answered by randomized controlled trials. Re-conceptualizing the issues
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will also lead to new research agendas. Research should also pose questions about the
relationship between TB and poverty in the Nepal context, and will have to address
questions around the ‘structural violence’ of civil war, internal migration, emerging
famine in the far west of the country and the relations of this to both developing TB,
and access to TB treatment. None of this, however, can be done under frames of
reference that need controlled populations for the comparison of treatment outcomes.
Anthropological research should be a part of the greater interpretive imagination –
that which comes from an appreciation of inter-disciplinarity. As the particular
contexts of the work and lives of those who have TB, and those who try to deal with
it, become exposed to ethnographic research so too will new framings and not always
easy questions arise. Rarely do anthropological data or interpretation fit the dominant
frames of reference. They can be ignored, or, a better understanding of the value of
such research can be developed.
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